Condition: Major Depressive Disorder (MDD) · Major Depressive Episode · Treatment-Resistant Major Depressive Disorder · Sponsor: Unity Health Toronto
The goal of this observational study is to learn about remote mental health monitoring technology for adults with treatment-resistant depression. The main question it aims to answer is: are digital mental health monitoring tools (an electronic data capture platform and wearable device (e.g., smartwatch or smart-ring)) feasible to implement alongside clinical treatment for depression? The secondary aim of this study is to inform preliminary clinical parameters for larger, definitive studies. Participants receiving neuropsychiatric treatment (repetitive transcranial magnetic stimulation, intravenous ketamine, or electroconvulsive therapy) as part of their regular medical care for treatment-resistant depression in the Interventional Psychiatry Program will have their clinical assessment data entered into a digital platform and will wear an accessory-based wearable device for the duration of treatment.
This description comes directly from the study's public registry record.
Dr. Venkat Bhat, M.D., F.R.C.P.C. · 416-360-4000 · venkat.bhat@unityhealth.to
Dr. Karisa Parkington, Ph.D. · 416-360-4000 · karisa.parkington@unityhealth.to
Always discuss trial participation with your own doctor first.
| St. Michael's Hospital, Unity Health Toronto | Toronto, Ontario, Canada | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06732089